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Abstract
Background: Current Genome-Wide Association Studies (GWAS) are performed in a single trait framework without
considering genetic correlations between important disease traits. Hence, the GWAS have limitations in discovering
genetic risk factors affecting pleiotropic effects.
Results: This work reports a novel data mining approach to discover patterns of multiple phenotypic associations
over 52 anthropometric and biochemical traits in KARE and a new analytical scheme for GWAS of multivariate
phenotypes defined by the discovered patterns. This methodology applied to the GWAS for multivariate
phenotype highLDLhighTG derived from the predicted patterns of the phenotypic associations. The patterns of the
phenotypic associations were informative to draw relations between plasma lipid levels with bone mineral density
and a cluster of common traits (Obesity, hypertension, insulin resistance) related to Metabolic Syndrome (MS). A
total of 15 SNPs in six genes (PAK7, C20orf103, NRIP1, BCL2, TRPM3, and NAV1) were identified for significant
associations with highLDLhighTG. Noteworthy findings were that the significant associations included a mis-sense
mutation (PAK7:R335P), a frame shift mutation (C20orf103) and SNPs in splicing sites (TRPM3).
Conclusions: The six genes corresponded to rat and mouse quantitative trait loci (QTLs) that had shown
associations with the common traits such as the well characterized MS and even tumor susceptibility. Our findings
suggest that the six genes may play important roles in the pleiotropic effects on lipid metabolism and the MS,
which increase the risk of Type 2 Diabetes and cardiovascular disease. The use of the multivariate phenotypes can
be advantageous in identifying genetic risk factors, accounting for the pleiotropic effects when the multivariate
phenotypes have a common etiological pathway.
Background
Genome-wide association studies (GWAS) have broa-
dened our knowledge on architectures of disease suscep-
tible loci for many common disease of public health
importance. A general approach for GWAS follows a
strategy to investigate the correlations between single
genetic variants and single traits within a univariate fra-
mework. The GWAS have not considered complicated
genetic nature such as pleiotropy that occurs due to
potential genetic correlation between different traits
[1,2]. Thus, it tends to be restricted to identify pleiotro-
pic genes that situated at common etiologic pathways of
correlated human diseases.
Patterns of pleiotropic effects have been observed
more with an increasing number of variants identified
through GWAS [3]. For instances, Winkler and collea-
gues identified a variant of TCF2 (Transcription Factor
2) associated with T2D [4], while a different variant in
the same gene was associated with an increased risk of
prostate cancer [5]. These two studies indicate that the
risk allele for prostate cancer protects from T2D with
an odds ratio of 0.91. In addition, two studies [3]
showed that the same variant in GDF5 associated with
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osteoarthritis [6,7].
As we have mentioned the examples above, previous
work has shown that ignoring pleiotropic effects may
cause imprecise phenotype definition of heterogeneous
samples or even spurious associations. A bias in sam-
pling cases and controls characterizing single traits
might be propagated since the sampling errors tend to
be correlated if the single traits were correlated. This
may confound the interpretation of results. Although
any loss of power occurred by selection of samples can
be recovered by increasing the sample size, the sample
size of the GWAS has cost constraints. With large sam-
ple sizes of several thousand cases and controls there
has been usually limited study power to detect alleles of
modest effect sizes (e.g., an odds ratio of 1.20) [8].
In this regard, incorporation of the multiple pheno-
types to the GWAS can be an alternative way to unravel
missing heritability in the GWAS and to find pleiotropic
genes. Even though the GWAS of multivariate pheno-
types are known to enhance the power of the GWAS
such an approach has not been well established.
To perform multiple phenotypes based GWAS, appli-
cation of traditional GWAS approaches has suffered
penalties from multiple testing problems caused by test-
ing multiple genome-wide scans of single traits sepa-
rately. This may diminish the power of GWAS due to
elevating heterogeneity and bias in samples. Statistically
classic multivariate methods have been applied to
GWAS of multivariate phenotypes to tackle in an effec-
tive manner. Such methods are likelihood-based mixed
effects model (LME) [9,10] and generalized estimating
equations (GEE) methods. Liu et al. suggested an exten-
sion of the GEE to test association analysis for a mixture
of continuous and binary traits [11]. Their work mani-
fested statistical power of bivariate association analysis
with two continuous traits, i.e. obesity and osteoporosis.
Their method is limited to bivariate traits and applicable
to independent samples.
O’Brien model [12] and its extension [13], which sug-
gested the integration of results from association tests of
single traits of a multivariate phenotype, can work well
for a homogeneous mean among individual tests of sin-
gle traits but not for heterogeneous ones. To overcome
this limitation, Yang et al. [2] improved O’Brien method
by use of a sample splitting method and a cross valida-
tion method as a screening tool for detecting pleiotropic
effects. Previous work has contributed to addressing
association tests for multivariate phenotypes. However,
there is still no standard method to be free from multi-
ple test problems and be accepted for multivariate phe-
notypes [11].
Much work have not investigated what types of single
traits can be correlated to induce multivariate
phenotypes. In this context, we aimed to discover novel
multivariate phenotypes from large scale epidemiological
data by a data mining approach and develop a scheme
to GWAS of multivariate phenotypes. In our previous
work [14], we reported the discovery of multivariate
phenotypes by applying association rule mining over 52
anthropometric and biochemical traits in Korea Associa-
tion Resource (KARE)[15] population. We showed an
analytical scheme for GWAS of the multivariate pheno-
type lowLDLhighTG, which means a negative relation
between low levels of LDL and high levels of TG. Our
preliminary results revealed that effect sizes (odds
ratios=1.44-2.38) of genetic loci associated with the mul-
tivariate phenotype were higher than genetic loci identi-
fied in the initial GWAS, while their p-values were less
significant than those in the initial GWAS. Those loci
cannot be detected within a single trait based
framework.
Here, we present a more sophisticated scheme for
refining association rules to extract patterns of phenoty-
pic associations and to visualize them graphically. As a
case study, we describe the results of GWAS for multi-
variate phenotype highLDLhighTG combining elevated
low density lipoprotein cholesterol (LDL-C) levels and
elevated triglyceride (TG) levels, which have an impor-
tant clinical implication in metabolic syndrome (MS).
An association rule which expresses patterns of multi-
variate phenotypes encoding partial correlations between
single traits specifies quantitative descriptions of the sin-
gle traits. Association rules can provide explicit bound-
aries of the single traits of multivariate phenotypes for
optimal selection of both cases and controls. This work
contributes a methodology for exploration in GWAS
analysis of multiple phenotype highLDLhighTG.
Methods
Data
We investigated 350K variants in 8,512 individuals in
Korea Association Resource (KARE) for performing
GWAS of multivariate phenotypes and mining patterns
of them. Additional details of quality-control and impu-
tation procedures have been reported in [15]. Gene
annotations refer to the human genome build hg18. Of
8,842 individuals in KARE, 1,853 having missing values
found in at least one of traits were removed. The indivi-
duals were described by a total of 52 traits (see Addi-
tional file 1), of which six traits (CRP, AST, ALT, r_gtp,
homa, creatin) extremely distributed were removed. The
resulting 6,998 individuals with 46 traits were employed
in association rule mining.
Association rule mining
The problem of discovery of multivariate phenotypes
from a set of single traits is transformed into finding
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approach we employed Association Rule Mining (ARM)
[16] to discover the patterns of phenotypic associations
expressed as association rules. We have previously
shown [14,17] that association rules detected by ARM
are informative and quantitative and have benefits to
interpret their meaning. Association rules have the form
R: X ® Y [c, s], where X (the Left-hand side or LHS)
and Y (the Right-hand side or RHS) are the body and
the head of a rule, respectively. c and s stand for confi-
dence and support to measure accuracy of rules. X and
Y are disjoint predicates (X ∩ Y = Ø). Each X and Y
consists of a conjunction of distinct predicates which
describe values of single traits. An association rule
expresses association of single traits X and Y and can be
derived to a multivariate phenotype.
The strength of the association rules can be measured
in terms of their support (s) and confidence (c). The
s u p p o r to far u l e( X® Y) is the probability that cases
in a database contain both X and Y. The confidence of
ar u l ei st h ep r o b a b i l i t yt h a tc a s e sc o n t a i nXc a na l s o
contain Y. Note that the head of a rule, Y, is restricted
to be one of the single traits which we are interested in
and X is a set of traits partially correlated with Y. Inter-
esting rules are manually extracted.
Discovery of multivariate phenotypes
Association rule generation and post filtering the rules
We used 10g Oracle Data Miner (ODM) which imple-
mented the APRIORI algorithm [16] to compute asso-
ciation rules. We set a minimum support and a
minimum confidence of 1% and 10%, respectively, to
detect rare patterns representing disease predisposing
cases more rather common features appeared in normal
cases.
If we set threshold too high for support (e.g., 20 %),
there may miss many interesting patterns involving the
low support with high confidence. Such low support
traits may correspond to rare associations of sing traits,
but whose patterns are still interesting to know. Most
patterns mined characterize common correlations
between traits, which are already well known. Domain
experts such as biologists may have different interesting
traits. Our strategy to find interesting rules is that we
set low support threshold, generate as many rules and
filter them by user interestingness measurements and
interesting traits as user constraints. High confidence
rules can misinform and do not consider the support of
the traits appearing in the rule head. One way to resolve
this problem is to apply a metric known as lift [18]:
Lift=P(X,Y)/P(X)×P(Y)
which calculates the ratio between the rule’sc o n f i -
dence and support of the single trait Y i nt h er u l ec o n -
sequence. Lift was originally called interest which
measures how many times more often X and Y occur
together than expected if they are statistically
independent.
The following example shows rule form constraints to
find interesting association rules containing single traits
such as high levels of TG (TG5) and low levels of LDL
(LDL1):
R1: ((TG5⊂LHS) ∨ (TG5⊂RHS)) ∧ (min_conf ≥ 0.7,
lift ≥ 1, min_sup ≥ 0.025),
R2: ((LDL1⊂LHS) ∨ (LDL1⊂RHS)) ∧ (min_conf ≥ 0.7,
lift ≥ 1, min_sup ≥ 0.025).
Visualization of phenotypic association
We employed graph-based techniques to visualize inter-
esting association rules using igraph package on R
2.12.0. A set of interest association rules represented
with an undirected edge weighted graph where vertices
represent traits and edges indicate relationships (i.e.
associations) between other traits in rules. Vertex size is
proportional to degrees of vertices.
A scheme of association analysis
An algorithm for association test
A multivariate phenotype(y) is defined as bivariate traits
(yi,y j) which can be a mixture of continuous and nom-
inal traits. The multivariate phenotype can be a con-
junction of predicates of single traits, as expressed one
or more association rules.
y=y i +y j
Association analysis for multivariate phenotype(y) is
performed by following tasks:
(1) Test a genome-wide scan for a multivariate pheno-
type (y): GWAS(y)
(2) Test genome-wide scans for singleton traits:
GWAS(yi), GWAS(yj)
(3) Calculate mORp
s where minus log odds ratio for
p-values of SNPs obtained from an association test of a
multivariate phenotype(y) over those from a single trait
(yi) as follows:
mOR Pvalue y Pvalue y p
yi
i =− () log ( ) / ( ) 10
(4) Prune SNPs by filtering strategies (see section
strategy for pruning SNPs)
(5) Repeat tasks 2~4 for other single trait (yj)
(6) A final set of SNPs is generated by the intersection
of two sets of SNPs survived from filtering steps which
prune SNPs more likely to affect either of single traits.
SNPs identified for an association test of a multiple
phenotype may include genetic variants more likely
affecting each of single traits which should be excluded.
Tasks 1 to 4 are subject to filtering steps to identify
genetic variants influencing the multivariate phenotype y
while the genetic variants much more likely to affect
single traits (yi and yj) are excluded by mORp
S (vide
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S measures the strength of association
of a multivariate phenotype against those of single traits.
Strategy for pruning SNPs
From a list of results of the association test for a multi-
variate phenotype, false positives of SNPs are pruned by
the following conditions and significant ones remain:
(1) P-values for an association test of multivariate phe-
notype ≤ 5×10
-4
(2) mORP
yi ≥ 1 and mORp
yj ≥ 1
(3) P-value of an indexed SNP ≤ 10
-5 and p-values of
clumped SNPs ≤ 10
-4 in order to evaluate formation of
LD.
There have been no generalized method to deal with
the multivariate phenotypes and the cut-off p-value for
a significant association in GWAS is not well defined.
The cut-off p-value for the multivariate phenotype is set
to be less stringent than usual GWAS which mostly set
a Bonferroni corrected p-value of 0.05 (P ≤ 1.43×10
-7
which is not corrected) since we consider a small sam-
ple size for cases and controls due to combination of
phenotypes. mORP
S ≥1 means that it is 10 times as
likely that SNPs are associated with a multivariate phe-
notype against a single one.
Application to GWAS of lipid levels
We applied to multivariate phenotype based GWAS to
relations between plasma lipid levels for an in-depth
study. Positive relations between TG and LDL-C can be
specified as multivariate phenotype highLDLhighTG,
which indicates high LDL-C of ≥ 130 mg/dl and high
TG of ≥ 180mg/dl extracted from 359 rules. Ranges of
TG and LDL-C levels for GWAS are adjusted for those
meeting the guidelines used in clinical researches.
An association test of highLDLhighTG seeks to iden-
tify single shared loci affecting both high levels of LDL-
C and TG while excluding ones affecting either of the
single traits LDL-C and TG. 545 cases and 680 controls
(Table 1 and see Additional file 2 for single traits) are
selected for GWAS of multivariate phenotype high-
LDLhighTG. SNPs influencing on either one of TG or
LDL-C traits were pruned from a list of significant SNPs
associated with highLDLhighTG. Case-control based
association scans and LD clumping were performed by
PLINK [19].
Results and discussion
Multiple phenotypic associations
Out of a total 3,792,566 rules mined, 765,318 rules of
which lift ≥ 1 and confidence ≥ 0.5 were retained.
136,551 rules encoded TG and LDL levels. Of 19,837
rules related to high TG levels, 191 interesting rules
represent low LDL-C and high TG in contrast to 509
rules that manifested high TG and high LDL-C levels.
Table 2 denotes the representative association rules (see
Additional file 3) and interpretation of rules refer to the
previous work [14].
Associations between high TG levels and MS related traits
Association patterns of single traits extracted from 359
rules containing high TG levels were visualized by a
connected graph (Figure 1). High TG trait ( TG5 in
Figure 1) connected with peculiar nodes representing
the 17 distinctive traits: Bone Mineral Density (BMD)
Table 1 Descriptive summary of samples
highLDL highTG Control (LDL ≤ 100 and TG ≤ 100, n=681) Case ( LDL ≥ 130 and TG ≥ 180, n=545)
Area/sex
n=individual
Ansung n=381 Ansan
n=300
Male n=233 Female n=458 Ansung
n=205
Ansan n=340 Male n=288 Female n=257
AGE 52.6 ± 9.45 45.7 ± 5.88 54.1 ± 9.34 47.3 ± 7.56 56.6 ± 8.20 50.1 ± 8.19 49.6 ± 7.99 55.8 ± 8.45
BMI 22.7 ± 3.06 23.2 ± 2.80 21.8 ± 2.71 23.4 ± 2.94 26.0 ± 2.84 25.9 ± 2.71 25.5 ± 2.58 26.4 ± 2.89
WHR 0.88 ± 0.06 0.79 ± 0.07 0.87 ± 0.06 0.83 ± 0.08 0.95 ± 0.05 0.87 ± 0.05 0.90 ± 0.05 0.90 ± 0.08
TCHL 148 ± 18.3 151 ± 15.61 149 ± 17.8 150 ± 16.9 240 ± 22.3 243 ± 24.6 242 ± 22.8 242 ± 24.9
HDL 50.3 ± 10.5 50.0 ± 10.5 51.0 ± 12.0 49.8 ± 9.70 42.4 ± 8.56 42.5 ± 7.66 42.2 ± 7.55 43.0 ± 8.48
LDL 81.8 ± 14.8 85.1 ± 11.7 81.6 ± 14.5 84.1 ± 13.1 150 ± 16.8 155 ± 20.9 152 ± 18.6 153 ± 20.7
TG 81.4 ± 13.4 81.0 ± 12.4 80.9 ± 14.5 81.4 ± 12.2 238 ± 51.7 231 ± 49.0 237 ± 52.3 230 ± 47.3
highLDL Control (LDL ≤ 100, n=2215) Case (LDL ≥ 130, n=2271)
Area/sex
n=individual
Ansung
n=1403
Ansan
n=812
Male
n=1024
Female
n=1191
Ansung
n=919
Ansan
n=1352
Male
n=1044
Female
n=1227
LDL 79.6 ± 16.6 84.1 ± 12.4 79.2 ± 17.3 83.0 ± 13.2 151 ± 17.9 155 ± 20.9 154 ± 19.5 153 ± 20.1
TG 157 ± 78.5 148 ± 78.0 169 ± 82.2 140 ± 72.5 146 ± 61.8 147 ± 61.3 152 ± 65.3 142 ± 57.6
highTG Control (TG ≤ 100, n=1914) Case (TG ≥ 180, n=1779)
Area/sex
n=individual
Ansung n=920 Ansan
n=994
Male n=700 Female
n=1214
Ansung
n=936
Ansan n=843 Male n=969 Female n=810
LDL 109 ± 29.7 118 ± 30.0 116 ± 31.9 112 ± 29.1 104 ± 33.7 122 ± 33.8 111 ± 35.8 115 ± 33.8
TG 81.4 ± 13.6 80.4 ± 13.5 80.0 ± 14.8 81.5 ± 12.7 248 ± 55.5 241 ± 53.6 248 ± 56.1 240 ± 52.6
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Page 4 of 14measure, distal radius SOS(DS); Blood components, HB,
WBC_B, PLAT, and HBA1C; and metabolic syndrome
(MS) (Daskalopoulou, et al., 2006) measures, obesity
(BMI, WHR and SUP), lipids (LDL, HDL, TCHL,
T_HDL, TG and NONHDL), hypertension (SBP and
DBP) and insulin resistance (GLU0, INS0, GLU60 and
GLU120), post-challenge insulin(INS60 and INS120).
The abbreviation of single traits refers to Figure 1.
Associations between high TG levels and a cluster of 4
common traits (obesity, insulin resistance, hypertension,
and hyperlipidemia) related to MS, were consistent with
the fact that MS increases T2D and cardiovascular dis-
eases (CVD) [20].
Associations between high TG levels and BMD
One of the noteworthy findings is the association
between low DS for the measure of BMD and high TG
levels. The associations between low DS and a cluster of
MS defined by the four common traits i.e. obesity,
hypertension, hyperlipidemia and insulin resistance with
high glucose levels and dissociation with insulin levels
(INS0, INS60, INS120) were in concordance with newly
reported work [21] that examined an association
between MS and bone health. There are negative rela-
tions between low DS associated with high levels of
lipids including TG, TCHL and LDL and positive rela-
tions between low DS with low levels of HDL [22].
More interesting finding was observed in that low DS
are associated with high levels of glucose but not with
insulin levels although the association between high glu-
cose levels or insulin resistance with BMD has been
inconclusive. In contrast, hyperglycemia is known for a
predictor of bone loss and osteoporotic fractures [23].
O u rf i n d i n gc a nb eas u g g e s t i v ee v i d e n c et h a to b e s i t y ,
hypertension and hyperlipidemia among MS related
traits might be associated with osteoporosis.
Associations with high LDL
High levels of LDL were shown positive relations with
BMI, glucose levels and plasma lipids including TCHL,
TG, and NONHDL as well as negative relations with
DS. We did not find associations between high LDL
levels and insulin levels. Interestingly, highLDL have
positive relations with single traits related to renal func-
tion such as Blood Urea Nitrogen (BUN) and Sodium in
Urine (SONA).
Pattern of multivariate phenotype highLDLhighTG
Among multiple phenotypic associations with high TG,
we considered the phenotypic associations which subdi-
vided samples into feasible sizes of cases and controls
for GWAS. We focused on contradictory relationship
between high TG levels (TG5 in Figure 1(a)) with low
or high levels of LDL (LDL1 in Figure 1(a) and LDL5 in
Figure 1(b)). That is, there are positive correlations:
between TG and LDL-C and TCHL; between LDL-C
and HDL as well as negative correlations: between TG
and LDL-C; between HDL and TG, LDL-C and TCHL.
Both single traits, high TG levels and high LDL levels,
shared common traits (BMI, PLAT, TCHL, and GLU0)
associated with themselves.
Combination of two single traits, high LDL and high
TG, introduces multivariate phenotype highLDLhighTG
which can amplify association strength with correlated
single traits by additive effects of the single traits. Out
of 17 associated traits, four traits (DS, GLU0, INS0, and
SONA) have more power in distinctively classifying
samples of highLDLhighTG into cases and controls (Fig-
ure 2).
The associations between the traits can be substan-
tiated in association rules encoding high TG levels
(Rules 1~14) and high LDL-C levels (Rules 15-18). The
rules were sorted and selected by their confidences.
As seen from above, there exist complicated associa-
tions among single traits. Selection of cases and controls
based on single traits without considering those associa-
tions may increase confounding effects in samples.
Compared with single traits based selection of cases and
Table 2 Representative association rules
Rule
#
Rule body Rule head Supp Conf Lift
Rules encoding highTG levels
1 LDL5, BMI5, TG5, TCHL5 ® NONHDL5 0.0157 1.0000 5.1732
2 GLU1205, TCHL5, LDL5,
TG5
® NONHDL5 0.0136 1.0000 5.1732
3 LDL5, TG5, TCHL5,
GLU05
® NONHDL5 0.0132 1.0000 5.1732
4 TG5, PLAT5, LDL5,
NONHDL5
® TCHL5 0.0127 1.0000 5.1465
5 GLU605, TG5, TCHL5,
LDL5
® NONHDL5 0.0126 1.0000 5.1732
6 TG5, LDL5, TCHL5, DS1 ® NONHDL5 0.0122 1.0000 5.1732
7 LDL5, INS1205, TCHL5,
TG5
® NONHDL5 0.0119 1.0000 5.1732
8 DBP5, TG5, LDL5, TCHL5 ® NONHDL5 0.0119 1.0000 5.1732
9 INS605, TCHL5, TG5,
LDL5
® NONHDL5 0.0116 1.0000 5.1732
10 TG5, TCHL5, INS05, LDL5 ® NONHDL5 0.0107 1.0000 5.1732
11 TG5, LDL5, SBP4, TCHL5 ® NONHDL5 0.0107 1.0000 5.1732
12 TG5, TCHL5, WHR5, LDL5 ® NONHDL5 0.0107 1.0000 5.1732
13 T_HDL5, NONHDL5,
LDL4, HDL2
® TG5 0.0102 0.8875 4.1105
14 TCHL2, LDL1, NONHDL2,
PH1
® TG5 0.0100 0.8333 3.8595
Rules encoding highLDL levels
15 TCHL5, NONHDL5,
GLU605
® LDL5 0.0405 0.8324 4.2651
16 DS1, NONHDL5, GLU605 ® LDL5 0.0155 0.8182 4.1924
17 NONHDL5, SONA4,
TCHL5
® LDL5 0.0242 0.8450 4.3297
18 TG3, BUN5, NONHDL5 ® LDL5 0.0114 1.0000 5.1239
Definition of trait names refers to Figure 1.
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power to distinguish cases from controls.
GWAS results of Plasma lipid levels
We identified total 50 variants associated with high-
LDLhighTG and 15 are located in six genes (PAK7,
C20orf103, NRIP1, BCL2, TRPM3,a n dNAV1)( T a b l e3
and Figure 3). It is interesting to know that rs11700112
of PAK7 on 20p12.2 is in a missense mutation by substi-
tution of arginine (CGA) by proline (CCA). Clinical
association has not yet been found with this variant. It
is located within a LD block (530kb) with other four
SNPs, of which two (rs6140956 and rs6133716) are in
intronic region of C20orf103. It is worth to note that
C20orf103 contains a frameshift mutation at
rs72238296, which is 755 bases upstream of rs6140956
in the same gene (Table. 3 and Figure 4(a)). The frame-
shift mutation is known for a cause of a hypercholester-
olemia [24].
A strong LD block (81kb length) with high r
2 values
(r
2 ≥ 0.90) detected across three SNPs (rs4744611,
rs7039780 and rs4744608) (Figure 5(b)) of TRPM3 on
chromosome 9 (9q21.11-q21.12) that is relatively close
to regions linked to coronary artery disease [25]. Among
nine splice variants of TRPM3, splice variants 7 and 8
do not include the three SNPs identified (Figure 5(a)).
This observation suggests that SNPs can make different
functional effects on splice variants. Although no firm
genetic linkage to disease has been established and not
much report on the properties of TRPM3,f u n c t i o n a l
activity of TRPM3 is relevant to contractile and prolifer-
ating vascular smooth muscle cells. Recent work [26]
investigated the relevance and regulation of TRPM3 in
vascular biology and showed that elevated cholesterol
can act as a negative regulator of TRPM3.
Two SNPs of BCL2 gene on chromosome 18
(18q21.33) were identified. BCL2, which is involved in a
number of cancers including melanoma, breast
Figure 1 Visualization of phenotypic associations with connected graphs.
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ulators of cardiac myocyte apoptosis. A distinct support
for relevance of BCL2 to cardio vascular disease (CVD)
was reported by recent finding [27] that PPARg pro-
tected cardiac myocytes from oxidative stress and apop-
tosis through upregulating BCL2 expression.
NRIP1 was reported to have an association with HDL
[28]. Recent studies identified a hepatocyte specific role
for NRIP1 as a cofactor for LXR in different ways,
namely serving as a coactivator in lipogenesis and as a
corepressor in gluconeogenesis [29]. NAV1 on chromo-
some 1q32.1, a human homolog of a C. elegans gene,
unc-53, is expressed in adult heart and the developing
brain. Clinical association has not been established with
it. Our results warrant that variants associated with
highLDLhighTG should be evaluated for further study.
It is important to emphasize that LD structures for the
six genes across three populations (YRI, CEU, JPT
+CHB) are distinct. The pattern of the strongest LD was
observed in JPT+CHB among the three. Whereas, the
Figure 2 Distribution of associated traits with multivariate and single traits. 1 and 2 stand for groups of controls and cases in samples of
traits respectively. (a), (b) and (c) stand for highLDLhighTG, high LDL and high TG respectively. Out of the 17 associated single traits with high
LDL and high TG, 9 single traits were selected for viewing due to keeping image resolution.
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Additional file 4).
In silico replication
In silico replication analysis was conducted for the 15
S N P si nt w or e g i o n a ls u b c o h o r t sa sw e l la sg e n d e r
groups (Table 4). Nine of 15 SNPs associated with high-
LDLhighTG were well reproducible in regional subco-
horts (P < 0.05), while p-values of six SNPs (p ≥ 0.05)
were on the borderline statistical significance. Five SNPs
in NIRP1 (rs2822994, rs2822998 and rs1041404) and
NAVI (rs665770 and rs529581) were more reproducible
in both regional subcohorts and gender groups.
Reproducibility of gender difference in the 15 SNPs
were as follows: PAK7 and NRIP1 were more effective
in women; BCL2, TRPM3 and NAV1 were more repro-
ducible in men. highLDLhighTG was more detectable in
w o m e nt h a nm a n( c
2 ≥44.9, p-value = 2.05 × 10
-11).
PAK7 and NRIP1 may lead to the gender specific sus-
ceptibility in concordance with previous work [30]
reporting more gender-specific effects for CVD in
women than men.
Comparison of general GWAS
Overall distribution of p-values for an association test
appeared to be less significant than those for general
Table 3 Genetic variants associated with highLDLhighTG
SNP Chr Base position SNP type gene Str- and Allele(+/-) Freq (+) P-value hLDLhTG OR mORP
LDL mORP
TG r
2
rs11700112 20 9495018 nonsyn PAK7 - G C 0.31 6.2×10
-5 1.44 3.25 1.58 1.00
rs6140956 20 9450080 intronic C20orf103 + C T 0.41 6.3×10
-5 1.40 2.79 1.85 0.56
rs6133716 20 9455931 intronic C20orf103 + A G 0.40 1.0×10
-4 1.39 2.58 1.75 0.59
rs9967942 20 9503781 intronic PAK7 - C A 0.34 9.6×10
-5 1.41 3.24 1.76 0.89
rs11087847 20 9504159 intronic PAK7 - T G 0.31 8.6×10
-5 1.43 3.02 1.59 0.99
rs2822994 21 15282928 intronic NRIP1 - A G 0.41 8.7×10
-5 1.40 2.46 2.59 1.00
rs2822998 21 15285230 intronic NRIP1 - C A 0.41 4.1×10
-4 1.35 2.09 2.12 0.97
rs1041404 21 15346738 intronic NRIP1 - A G 0.43 1.7×10
-4 1.37 2.38 2.33 0.64
rs9959874 18 59045526 intronic BCL2 - A G 0.15 1.2×10
-4 1.60 3.40 2.20 1.00
rs1893506 18 59044660 intronic BCL2 - G A 0.15 1.5×10
-4 1.59 3.31 2.08 1.00
rs4744611 9 72551280 intronic TRPM3 - G A 0.49 1.8×10
-4 1.36 1.93 3.14 1.00
rs7039780 9 72469777 intronic TRPM3 - G A 0.50 3.7×10
-4 1.34 1.57 2.98 0.90
rs4744608 9 72470797 intronic TRPM3 - G C 0.50 3.7×10
-4 1.34 1.52 2.99 0.90
rs665770 1 200014747 intronic NAV1 + A G 0.38 2.0×10
-4 1.38 2.65 1.54 1.00
rs529581 1 200016143 intronic NAV1 + C G 0.37 2.0×10
-4 1.38 2.59 1.59 0.99
rs693 2 21085700 coding APOB - A G 0.07 7.3×10
-4 1.83 0.04 2.21 -
SNP rs693 reported in a previous study (Kathiresan, et al, 2008) for associations between high TG and high LDL. The rs693 was pruned since its effect was
stronger in single traits high LDL than multivariate highLDLhighTG with borderline significance.
Figure 3 A manhattan plot for an association test of highLDLhighTG. Gene symbols in purple represents loci identified in previous GWAS of
lipids (Kathiresan, et al., 2008). SNPs in blue were pruned.
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Page 8 of 14GWAS. On the other hand, the p-values of significant
SNPs identified for multivariate phenotype high-
LDLhighTG were apparently more significant than those
for single traits highLDL and highTG (Figure 6). It is
noteworthy that effect sizes of the significant SNPs
which ranged between modest (odds ratios=1.38-1.60)
and intermediate effect sizes were comparable to those
for the general GWAS ranged from low to modest ones.
Pleiotropic patterns of quantitative trait loci
Pleiotropic patterns can be more precisely observed in
quantitative trait loci (QTLs) or LD blocks than at
SNPs. We examined QTLs and their associated pheno-
types for the six genes identified using Phenotype and
Disease Association track group in UCSC genome brow-
ser. The QTLs and their associated phenotypes were
extracted from rat and mouse QTLs from RAT DB and
MGI (Mouse Genome Information) (Table 5).
The six genes except NRIP1 share QTLs commonly
associated traits such as BMD and a cluster of common
traits defining MS. Those common traits in MS shared
by the six genes are blood pressure, non-insulin
dependent diabetes mellitus, renal function, cardiac
mass, and body weight. The phenotypic associations of
high TG and high LDL levels with low BMD examined
through rat and mouse QTL associations except NRIP1
have mapped in the regions of QTLs associated with
BMD. Furthermore it can be more support that TRPM3
was mapped to OMIM phenotypes such as osteosclero-
sis hardening bones, epilepsy, amyotrophic lateral sclero-
sis (ALS), of which association with CVD was reported
in a recent work [31]. Different genetic markers share
the same or similar OMIM phenotypes: BCL2 and
TRPM3 have in common with associating ALS; PAK7
and NAV1 have in common with similar phenotypes
Alzheimer disease (AD) and Parkinson disease (PD)
where a cross-talk between MS and AD was reported
[32].
In summary, our results suggest that the genetic mar-
kers identified with multivariate phenotype high-
LDLhighTG have phenotypic associations with common
traits in MS. The common traits in MS, particularly
hyperlipidemia, may be linked to pathogenic associations
with osteosclerosis and neurodegenerative disorders
Figure 4 P-value distributions of association tests for highLDLhighTG and single traits highTG and highLDL. Points in red are significantly
identified SNPs in the association test of highLDLhighTG. highLDLhighTG is presented with hLDLhTG and single traits highTG and highLDL are
presented in hTG and hLDL respectively.
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Page 9 of 14Figure 5 Genomic features for LD structures in HapMap populations.
Table 4 Replication of GWAS of highLDLhighTG
SNP Ansung Ansan Combined Male Female Combined
LDLTG
n=205
LDL-C
n=919
TG
n=936
LDLTG
n=340
LDL-C
n=1352
TG
n=843
LDLTG
n=545
LDLTG
n=288
LDL-C
n=1044
TG
n=969
LDLTG
n=257
LDL-C
n=1227
TG
n=810
LDLTG
n=545
rs11700112 2.6×10
-2 0.1818 0.3849 3.1×10
-2 0.7172 0.0172 2.8×10
-2 1.8×10
-1 0.4161 0.6321 1.0×10
-3 0.0967 0.0072 9.2×10
-2
rs6140956 8.8×10
-4 0.1770 0.1017 7.1×10
-2 0.7749 0.0332 3.6×10
-2 1.1×10
-1 0.6353 0.3125 8.4×10
-4 0.2317 0.0096 5.6×10
-2
rs6133716 1.8×10
-3 0.2691 0.0748 9.3×10
-2 0.7603 0.0701 4.7×10
-2 1.1×10
-1 0.9550 0.2231 1.9×10
-3 0.1757 0.0259 5.8×10
-2
rs9967942 2.6×10
-2 0.3476 0.4816 4.1×10
-2 0.6707 0.0198 3.3×10
-2 4.1×10
-1 0.2925 0.8325 6.9×10
-4 0.1545 0.0072 2.0×10
-1
rs11087847 1.9×10
-2 0.1531 0.3200 3.5×10
-2 0.7218 0.0151 2.7×10
-2 1.5×10
-1 0.4459 0.5424 1.1×10
-3 0.0750 0.0062 7.4×10
-2
rs2822994 1.1×10
-1 0.1582 0.2536 2.9×10
-5 0.0158 0.0019 5.4×10
-2 1.5×10
-2 0.4400 0.0060 2.4×10
-4 0.0045 0.1282 7.9×10
-3
rs2822998 1.2×10
-1 0.1985 0.2456 7.4×10
-5 0.0172 0.0043 5.8×10
-2 3.2×10
-2 0.4875 0.0084 2.9×10
-4 0.0101 0.1361 1.6×10
-2
rs1041404 1.6×10
-3 0.0668 0.0357 3.1×10
-3 0.0274 0.0338 2.4×10
-3 7.8×10
-3 0.3843 0.0049 4.4×10
-4 0.0094 0.0939 4.1×10
-3
rs9959874 1.2×10
-1 0.4953 0.1942 1.1×10
-3 0.0540 0.2536 5.9×10
-2 4.3×10
-3 0.4620 0.0720 1.8×10
-1 0.2007 0.9606 9.3×10
-2
rs1893506 1.2×10
-1 0.4953 0.1942 1.3×10
-3 0.0584 0.2616 5.9×10
-2 5.3×10
-3 0.4620 0.0771 1.8×10
-1 0.2018 0.9797 9.4×10
-2
rs4744611 1.7×10
-2 0.9652 0.0078 4.3×10
-2 0.0090 0.8933 3.0×10
-2 1.1×10
-3 0.0113 0.1925 1.8×10
-1 0.6221 0.4880 9.1×10
-2
rs7039780 7.8×10
-3 0.6334 0.0107 1.4×10
-1 0.0238 0.7387 7.6×10
-2 2.2×10
-3 0.0080 0.2893 2.2×10
-1 0.6317 0.4947 1.1×10
-1
rs4744608 7.8×10
-3 0.5846 0.0122 1.6×10
-1 0.0253 0.6955 8.2×10
-2 1.8×10
-3 0.0074 0.2650 2.6×10
-1 0.6317 0.5936 1.3×10
-1
rs665770 2.3×10
-2 0.2715 0.3219 4.7×10
-2 0.0747 0.3156 3.5×10
-2 1.6×10
-2 0.5529 0.1529 8.1×10
-2 0.0321 0.6182 4.9×10
-2
rs529581 2.2×10
-2 0.2498 0.3413 4.5×10
-2 0.0524 0.3337 3.4×10
-2 2.4×10
-2 0.5012 0.1932 6.2×10
-2 0.0260 0.5976 4.3×10
-2
rs693 8.0×10
-3 0.0889 0.2148 1.1×10
-2 0.0045 0.0396 9.6×10
-3 2.1×10
-3 0.0373 0.0147 2.8×10
-2 0.0056 0.6146 1.5×10
-2
n represents number of cases.
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Page 10 of 14including AD and PD influenced by pleiotropic genetic
factors. Thus, the genetic markers identified in our work
can have pleiotropic effect on MS, BMD and neurode-
generative disorders.
Gene network analysis using protein-protein interactions
We explored possible functional relationships between
five of six genes associated with highLDLhighTG using
STRING, a database of predicted protein-protein inter-
actions (PPI). We obtained 5 different networks of genes
interacting with each of five genes by confidence of
association evidence (≥ 0.5). Each of the gene networks
(Figure 7) was mapped to KEGG pathways and exam-
ined pathways in common. Four genes i.e. BCL2, NAV1,
NIRP1 and TRPM3 interact with genes (CASP7, BACE1,
SDHB, TRPC6) in AD and PD pathways, while BCL2
and NIRP1 shared Huntington’s disease as well as AD.
In particular, three genes i.e. BCL2, PAK7,a n dNIRP1
shared pathways in cancer and other pathways, support-
ing our hypothesis that multivariate phenotypes have
Figure 6 Scatter plots for p-value for a multivariate trait versus single traits.
Table 5 Phenotypes associated with QTLs mapped to 6 genes identified
Gene(s)
(chromosome
band)
OMIM phenotype (OMIM number) Phenotypes for rat QTL from RGD Phenotypes for mouse QTL from MGI
PAK7,
C20orf103
(20p12.2)
Body mass index(608559),
Atopic dermatitis(605804),
Systemic lupus erythematosus(610065),
Glaucoma(608696),
Alzheimer disease(607116)
Blood pressure, Body weight,
Cardiac mass, Stress response,
Non-insulin dependent diabetes mellitu, Renal
disease susceptibility, Thymus enlargement
suppressive
Blood glucose level,
Type 2 diabetes mellitus,
Bone mineral density, Crescentic
glomerulonephritis, Modifier of retinal
degeneration
NRIP1
(21q11.2)
Myeloproliferative syndrome(159595)
Narcolepsy(609039), Autism(610838)
Testicular tumor resistance
BCL2
(18q21.33)
Orthostatic hypotensive disorder
(143850), Insulin-dependent diabetes
mellitus(601941), Amyotrophic lateral
sclerosis(606640)
Blood pressure, Cardiac cell morphology,
Insulin dependent diabetes mellitus, Renal
function
Bone mineral density
TRPM3
(9q21.11
-9q21.13)
Hematocrit/hemoglobin quantitative trait
(609320), Cataract(605749),
Pelvic organ prolapse(613088),
Deafness (chromosome 9q21.11
duplication syndrome)(613558),
Epilepsy(611631), paraplegia(607152),
Otosclerosis(612096), Spastic
Amyotrophic lateral sclerosis(105550)
Blood pressure, Body weight,
Heart rate, Stress response, Cardiac mass,
Glucose level, Lipid level,
Renal function, Kidney mass, Renin
concentration,
Thyroid stimulating hormone level,
Abnormal inflammatory response,
Hepatocarcinoma susceptibility,
Atherosclerosis,
Bone mechanical trait,
Autoimmune aoritis,
Cataract severity
NAV1
(1q32.1)
Inflammatory bowel disease(612381),
Pseudohypoaldosteronism(145260),
Parkinson disease(613164),
Glomerulopathy(601894)
Blood pressure, Cardiac mass,
Stress response, Renal function,
Thymus enlargement,
Abnormal inflammatory response
Crescentic glomerulonephritis,
Bone mineral density
Phenotypes associated with QTLs were extracted from Phenotype and Disease Association tracks in UCSC genome browser. Phenotypes for OMIM, rat QTL,
mouse QTL corresponded to OMIM phenotype loci, RGD RAT QTL and MGI Mouse QTL tracks respectively.
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Page 11 of 14common etiology pathways when they are affected by
pleiotropic genetic factors.
Conclusions
We have showed a methodology to identify genetic mar-
kers associated with multivariate phenotypes derived
from patterns of phenotypic associations discovered by
ARM. An application of a large scale mining approach
to anthropometric and biochemical traits has not been
previously reported.
The patterns of phenotypic associations were visua-
lized with connected graphs which were informative to
draw relations between plasma lipid levels with BMD
and a cluster of common traits (Obesity, hypertension,
insulin resistance) related to MS. These putative pat-
terns of the phenotypic associations were in concor-
dance with the fact that MS increases T2D and CVD
[20]. More interesting finding was observed in that
BMD was associated with high levels of glucose but not
with insulin levels although the association between
high glucose levels or insulin resistance with BMD has
been inconclusive. We suggest that multiple phenotypic
associations between plasma lipid levels with BMD and
common traits in MS, be affected by the common genes
harbouring pleiotropic effects.
For the identification of pleiotropic genes, we derived
multivariate phenotype highLDLhighTG from the asso-
ciation patterns of two single traits high LDL and high
TG, which subdivided samples into feasible sizes of
cases and controls for GWAS. Multivariate phenotype
highLDLhighTG increased the strength of phenotypic
associations with the correlated single traits by additive
effect of multiple single traits. Out of 17 traits linked to
single traits high LDL and high TG, four traits (DS,
GLU0, INS0, and SONA) have more power in distinc-
tively classifying samples of highLDLhighTG into cases
and controls when the single traits were combined into
the multivariate phenotype.
Our approach to GWAS of multivariate high-
LDLhighTG identified 15 SNPs in six genes (PAK7,
C20orf103, NRIP1, BCL2, TRPM3, and NAV1). While p-
values (9.6 × 10
-5 ≤ P ≤ 1.2 × 10
-4) of genetic variants in
the six genes were less significant than those identified
in general GWAS due to limited sizes of the sample
those genes were not detectable within univariate frame-
work of the GWAS. Effect sizes (odds raios=1.34-1.60)
of the variants ranged between modest and intermediate
s i z e sw e r ec o m p a r a b l et ot h o s ei nt h eg e n e r a lG W A S .
Relevance of the six genes to CVD in MS was appar-
ently explained in previous work.
According to analysis based on rat and mouse QTL
DB, our results suggest that the six genes were mapped
to QTLs associated with common traits related to MS,
supporting that highLDLhighTG represents one of pleio-
tropic patterns related to MS and the six genes asso-
ciated with it can influence the pleiotropic effects on
MS. In particular, we showed possibility that hyperlipi-
demia may be linked to pathogenic associations with
osteoporosis and neurodegenerative disorders including
AD and PD by incorporating associations of OMIM
Figure 7 Gene networks constructed from interacting proteins. Solid lines in red stand for genes in pathways for AD, PD, HD, and ALS.
Gene symbols in black are involved in chemokine, MAPK and Wnt signaling pathways. Dashed lines in red represent genes mapping to
pathways in cancer from KEGG DB or specific cancer related pathways annotated by PANTHER and DAVID functional annotations.
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Page 12 of 14phenotypes with PPI networks for the six genes. We
have found that four genes i.e. BCL2, NAV1, NIRP1 and
TRPM3 may share AD and PD pathways where interact-
ing genes with them are involved. Three genes i.e. BCL2,
PAK7,a n dNIRP1 also share common pathways in
cancer.
Clinical association studies for 4 genes i.e. PAK7,
C20orf103, TRPM3 and NAV1 have not yet been found
although characteristics of genomic features for the four
genes are also suggestive to investigate further study.
Our work emphasize that multivariate phenotypes based
GWAS can identify pleiotropic genes that share com-
mon etiology pathways.
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